Top Markets
Coin of the day
Parenteral Drugs (India) Ltd. Parenteral Drugs (India) Ltd.

Parenteral Drugs (India) Ltd.

PDPL
Rang in Aktien #38236
Parenteral Drugs (India) Limited operates as an India-based healthcare... Parenteral Drugs (India) Limited operates as an India-based healthcare enterprise, specializing in the production of a diverse range of pharmaceutical goods. Its offerings encompass various medicinal products, including intravenous and inhalation therapies, as well as veterinary infusions. The company's extensive product portfolio further comprises various intravenous (IV) solutions, such as those containing carbohydrates and electrolytes, diuretics, and solutions for dialysis and irrigation. Additionally, they provide anti-infective, anti-fungal, oncology, and anesthesia medications. The firm maintains a significant international presence, exporting its goods to numerous nations including Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. Established in 1983, Parenteral Drugs (India) Limited's operations are headquartered in Indore, India.
Aktienkurs
$0.03200404
Zuletzt synchronisiert: 2024-07-23
Marktkapitalisierung
$1.12M
Veränderung (1 Tag)
-8.12%
Veränderung (1 Jahr)
0.00%
Land
IN
Handel Parenteral Drugs (India) Ltd. (PDPL)

Kategorie

EPS für Parenteral Drugs (India) Ltd. (PDPL)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Parenteral Drugs (India) Ltd. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Parenteral Drugs (India) Ltd. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber